Jiangxi Dadi Pharmaceutical

Jiangxi Dadi Pharmaceutical is a comprehensive pharmaceutical enterprise based in China, specializing in the research, development, production, and sale of Active Pharmaceutical Ingredients (APIs) and finished drug products. The company is a leading manufacturer of nitroimidazole derivatives, including Metronidazole, Tinidazole, and Ornidazole, which are widely used to treat anaerobic bacterial and protozoal infections. Operating from large-scale, GMP-compliant facilities in Jiangxi Province, the company serves both the domestic Chinese market and international clients across Southeast Asia and South America. In addition to its core anti-infective portfolio, Jiangxi Dadi produces medications for cardiovascular health and gastrointestinal disorders. The company is listed on the National Equities Exchange and Quotations (NEEQ) and is recognized as a high-tech enterprise in its region.